Ask AI
Psoriasis Treatment Strategies and Comorbidities

CE / CME

Psoriasis Treatment Strategies That Consider Comorbidities for Patients With Moderate to Severe Disease

Physician Assistants/Physician Associates: 0.50 AAPA Category 1 CME credit

Nurse Practitioners/Nurses: 0.50 Nursing contact hour

Physicians: maximum of 0.50 AMA PRA Category 1 Credit

ABIM MOC: maximum of 0.50 Medical Knowledge MOC point

Released: July 01, 2025

Expiration: June 30, 2026

Pretest

Progress
1 2 3
Course Completed
Please answer the questions below.
1.

A 40-yr-old man presents with long-standing plaque psoriasis involving 15% of his BSA. He has tried topical steroids and phototherapy with minimal improvement. He is otherwise healthy. The dermatologist recommends starting an IL-23 inhibitor. Which of the following best explains the rationale for using an IL-23 inhibitor in this patient?

2.

A 32-yr-old man with a 10-yr history of plaque psoriasis presents with worsening skin lesions despite topical therapy. His medical history is significant for moderate Crohn’s disease, which is currently active. The dermatologist is considering staring a biologic therapy. Which of the following drug classes is generally avoided in patients with PsO who have active IBD?